Your browser doesn't support javascript.
loading
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial.
Zhou, Ai-Ping; Bai, Yuxian; Song, Yan; Luo, Hong; Ren, Xiu-Bao; Wang, Xiuwen; Shi, Benkang; Fu, Cheng; Cheng, Ying; Liu, Jiyan; Qin, Shukui; Li, Jun; Li, Hanzhong; Bai, Xianzhong; Ye, Dingwei; Wang, Jinwan; Ma, Jianhui.
Afiliação
  • Zhou AP; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Bai Y; Harbin Medical University Affiliated Tumor Hospital, Harbin, Heilongjiang, People's Republic of China.
  • Song Y; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Luo H; Chongqing Cancer Hospital, Chongqing, Chongqing, People's Republic of China.
  • Ren XB; Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Wang X; Qilu Hospital of Shandong University, Jinan, People's Republic of China.
  • Shi B; Qilu Hospital of Shandong University, Jinan, People's Republic of China.
  • Fu C; Liaoning Province Tumor Hospital, Shenyang, Liaoning, People's Republic of China.
  • Cheng Y; Jilin Cancer Hospital, Changchun, People's Republic of China.
  • Liu J; West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
  • Qin S; The 81st Hospital of Chinese PLA, Nanjing, Jiangsu, People's Republic of China.
  • Li J; Gansu Province Cancer Hospital, Lanzhou, People's Republic of China.
  • Li H; Peking Union Medical College Hospital, Beijing, People's Republic of China.
  • Bai X; Guangxi Medical University Affiliated Tumor Hospital, Nanning, Guangxi, People's Republic of China.
  • Ye D; Cancer Hospital of Fudan University, Shanghai Shanghai, People's Republic of China.
  • Wang J; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Ma J; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China majianhui@csco.org.cn.
Oncologist ; 24(8): e702-e708, 2019 08.
Article em En | MEDLINE | ID: mdl-30902918
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Carcinoma de Células Renais / Sunitinibe / Indóis / Neoplasias Renais Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Carcinoma de Células Renais / Sunitinibe / Indóis / Neoplasias Renais Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article